Hongli Group Inc 6-K, filed Oct 5, 2026
Hongli Group Inc. (HLP)
About this 6-K
Hongli Group Inc filed this 6-K on October 5, 2026.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Hongli Group Inc.
(Exact name of registrant as specified in its charter)
No. 777, Daiyi Road,
Changle County, Weifang City,
Shandong Province, China, 262400.
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Incorporation by Reference
This report on Form 6-K is hereby incorporated by reference into (i) the registration statements of Hongli Group Inc. (the “Company”) on Form F-3 (File Nos. 333-284050 and 333-289457), as amended, and (ii) the registration statement on Form S-8 of the Company (File No. 333-278321), and into the prospectuses outstanding under the foregoing registration statements, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. The information in the attached Exhibit 99.1 shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Change of Director
Effective September 29, 2026, Mr. Jie Liu has resigned as the chairman of the Company’s board of directors (the “Board”). Effective on the same day, Mr. Chenglong Yang has resigned as a member of the Board and has also stepped down from all positions on the committees of the Board. Mr. Liu’s and Mr. Yang’s resignations from the Board were due to personal reasons and did not result from any dispute or disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Mr. Liu continues to serve as Chief Executive Officer of the Company.
On September 29, 2026, the Board approved the appointment of Mr. Michael Weichun Zhang to serve as the chairman of the Board, effective immediately.
Mr. Michael Weichun Zhang, age 57, has served as our director and chairman of the board as of September 29, 2026. Mr. Zhang has extensive experience in private equity fund management, capital allocation, business management and strategic oversight. Since March 2015, he has served as Managing Partner of H Alpha Management, a private equity fund management firm, where he is responsible for the firm's strategic direction and overall operations. He also serves as a director of Anbio Biotechnology, a U.S. publicly traded company, on whose board he is a member of the audit, compensation, and nominating and corporate governance committees, and as a director of Summa Innovations LLC, Eminence Capital LLC, Winnix Biosciences, Inc., and Cultiva Medical Technology Co., Ltd. Mr. Zhang holds an MBA in Finance from Yale University and a Bachelor of Science in Finance from Indiana University Bloomington.
There is no arrangement or understanding between Mr. Zhang and any other person pursuant to which they were selected as an officer and a director of the Company, and there is no family relationship between Mr. Zhang and any of the Company’s other directors or executive officers. Since the beginning of the Company’s last fiscal year, there have been no transactions, and there are no currently proposed transactions, in which the Company was or is to be a participant and in which Mr. Zhang had or will have a direct or indirect material interest that would be required to be reported under Item 404(a) of Regulation S-K.
In connection with the appointment, the Company has entered into a director offer letter and an indemnification agreement with Mr. Zhang. The terms of these agreements are consistent with the Company’s standard arrangements for its non-employee directors. The forms of the director agreement and the indemnification agreement are included as Exhibits 10.1 and 10.2, respectively, to this report on Form 6-K.
On October 5, 2026, the Company issued a press release entitled “Hongli Group Inc. Announces Appointment of Mr. Michael W. Zhang as Chairman of the Board”, a copy of which is attached hereto as Exhibit 99.1.
1
EXHIBIT INDEX
2
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HONGLI GROUP INC. | ||
| Date: October 5, 2026 | By: | /s/ Jie Liu |
| Jie Liu | ||
| Chief Executive Officer | ||
3
Exhibit 99.1
Hongli Group Inc. Announces Appointment of Mr. Michael W. Zhang as Chairman of the Board
WEIFANG, China, October 5, 2026 /PRNewswire/ — Hongli Group Inc. (the “Company”) (Nasdaq: HLP), a cold roll formed steel profile manufacturer, today announced a leadership transition within its Board of Directors (the “Board”). Effective September 29, 2026, Mr. Michael W. Zhang has been appointed as the new Chairman of the Board. He succeeds Mr. Jie Liu, who resigned as the Chairman of the Board effective the same day. Mr. Liu will continue to serve as Chief Executive Officer of the Company.
Additionally, Mr. Chenglong Yang has stepped down as a Director on the Board and a member of all committees under the Board, effective September 29, 2026. Mr. Liu’s and Mr. Yang’s resignations were both due to personal reasons and did not result from any dispute or disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Mr. Michael W. Zhang brings extensive capital markets and corporate governance experience to the Company. Mr. Zhang has extensive experience in private equity fund management, capital allocation, business management and strategic oversight. Since March 2015, he has served as Managing Partner of H Alpha Management, a private equity fund management firm, where he is responsible for the firm's strategic direction and overall operations. He also serves as a director of Anbio Biotechnology, a U.S. publicly traded company, on whose board he is a member of the audit, compensation, and nominating and corporate governance committees, and as a director of Summa Innovations LLC, Eminence Capital LLC, Winnix Biosciences, Inc., and Cultiva Medical Technology Co., Ltd.
Mr. Zhang holds an MBA in Finance from Yale University and a Bachelor of Science in Finance from Indiana University Bloomington.
“We are pleased to welcome Mr. Zhang as Chairman of the Board,” said Jie Liu, Chief Executive Officer of the Company. “His deep background in financial markets, capital structure strategy, and corporate growth will provide valuable governance and strategic oversight as the Company advances its business initiatives.”
“I am honored to serve as Chair of the Board,” said Michael W. Zhang. “The Company has built a strong foundation, differentiated market position, and a talented leadership team focused on driving long-term growth. I look forward to partnering closely with Mr. Jie Liu, our Board, and the broader management team as we seek to diversify from traditional cold roll-formed steel profile manufacturing into next-generation clean energy and solid-state lithium battery technologies, and endeavor to create long-term value for our shareholders.”
About Hongli Group Inc.
Hongli Group Inc. is a Cayman Islands holding company, and through a series of contractual arrangements, consolidates the financial results of Shandong Hongli Special Section Tube Co., Ltd. and its subsidiaries (collectively, “Hongli Operating Group”). Hongli Operating Group is a cold roll formed steel profile manufacturer with operating subsidiaries in China. Hongli Operating Group designs, customizes and manufactures cold roll formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture and transportation. The Hongli Operating Group, with over 25 years of operating history, has developed customers in more than 30 major cities in China as well as a global network including South Korea, Japan and the United States. Hongli Operating Group currently has 11 cold roll forming production lines and produces a variety of distinct profile products in a broad range of materials, sizes and shapes.
Forward-Looking Statements
Forward-looking statements include statements
concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are
other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,”
“should,” “believe,” “expect,” “anticipate,” “project,” “estimate,”
“continue,” “seek,”
“endeavor” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements.
Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results
to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to
uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies,
the Company’s future business development and plans for future business development, including its financial conditions and results
of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology,
government regulations, import and export restrictions, fluctuations in general economic and business conditions, the Company’s
ability to comply with Nasdaq continued listing standards and assumptions underlying or related to any of the foregoing and other risks
contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among
others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors
are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation
to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For more information, please contact:
Hongli Group Inc.
| Mr. Jie Liu | |
| Email: zjf@hongli-profile.com | |
| Tel: +86 0536-2180886 |